Projects per year
Search results
-
Active
A Phase 1/2, First-in-Human Study of the Menin-KMT2A (MLL1) Inhibitor Bleximenib in Participants With Acute Leukemia
Shah, S. (PI), Ganguly, S. (Key Personnel), Mai, H. P. (Key Personnel) & Pingali, S. R. (Key Personnel)
10/25/24 → …
Project: Clinical Trial
-
Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) with Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib
Pingali, S. R. (PI), Ganguly, S. (Key Personnel), Mathur, S. (Key Personnel), Shah, S. (Key Personnel) & Yi, Q. (Key Personnel)
7/29/24 → …
Project: Clinical Trial
-
IMPACT ON SURVIVAL OF FAITH-BASED SPIRITUAL CARE OR PSYCHOTHERAPY COMBINED WITH PALLIATIVE CARE VERSUS PALLIATIVE CARE ALONE IN PATIENTS WITH NON-CURATIVE MALIGNANCIES
Mai, H. P. (PI), Abdelrahim, M. (Key Personnel), Chang, J. C. (Key Personnel), Ganguly, S. (Key Personnel), Heyne, K. (Key Personnel), Mathur, S. (Key Personnel), Niravath, P. A. (Key Personnel), Pingali, S. R. (Key Personnel), Shah, S. (Key Personnel), Sun, K. (Key Personnel), Venta, L. A. (Key Personnel) & Zhang, J. (Key Personnel)
6/19/24 → …
Project: Clinical Trial
-
Open-Label, Multicenter, Phase 1 Study to Assess the Safety of P-BCMA-ALLO1 in Subjects with Relapsed / Refractory Multiple Myeloma (MM)
Ganguly, S. (PI), Mai, H. P. (Key Personnel), Pingali, S. R. (Key Personnel) & Shah, S. (Key Personnel)
3/21/24 → …
Project: Clinical Trial
-
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
Ganguly, S. (PI), Mai, H. P. (Key Personnel), Petkova, J. (Key Personnel), Pingali, S. R. (Key Personnel) & Shah, S. (Key Personnel)
3/30/23 → …
Project: Clinical Trial
-
ER stress response and chronic lymphocytic leukemia
Hu, C.-C. A. (PI), Pingali, S. R. (Key Personnel) & Tang, C.-H. A. (Key Personnel)
9/3/21 → …
Project: Clinical Trial
-
Targeting ER stress response in B-cell chronic lymphocytic leukemia
Hu, C.-C. A. (PI), Pingali, S. R. (Key Personnel) & Tang, C.-H. A. (Key Personnel)
4/1/21 → 3/31/25
Project: Federal Funding Agencies
-
Circulating tumor DNA 5-hydroxymethylcytosine as a novel biomarker for cancers.
Li, Z. (PI), Abdelrahim, M. (Key Personnel), Chang, J. C. (Key Personnel), Darcourt, J. (Key Personnel), Pingali, S. R. (Key Personnel), Sahay, S. (Key Personnel), Shah, S. (Key Personnel), Singh, M. (Key Personnel), Zhang, J. (Key Personnel), Zhou, S. (Key Personnel) & Zu, Y. (Key Personnel)
1/10/19 → …
Project: Clinical Trial
-
EAY131 - Molecular Analysis for Therapy Choice (MATCH)
Bernicker, E. H. (PI), Chang, J. C. (CoI), Darcourt, J. (CoI), Heyne, K. (CoI), Kamat, A. A. (CoI), Pingali, S. R. (CoI) & Singh, M. (CoI)
9/20/16 → 9/20/41
Project: Federal Funding Agencies